Patent directory · USPTO A61K / A61P
Patents matching “UNIVERSITY OF CONNECTICUT”
133 pharma patents match "UNIVERSITY OF CONNECTICUT" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 133 pharmaceutical patents matching "UNIVERSITY OF CONNECTICUT" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9353175
Use of antagonists targeting metallothionein to treat intestinal inflammation
granted -
US 9303053
Compositions and methods to treat cardiac diseases
granted -
US 9248172
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
granted -
US 9247910
Artificial tissue systems and uses thereof
granted -
US 9101575
Methods of inhibiting vascular permeability and apoptosis
granted -
US 9078832
Biomimetic scaffold for bone regeneration
granted -
US 8940288
Method for treating cancer by administering IL-15 and IL-15Ralpha complexes
granted -
US 8927275
Differentiation of human embryonic and induced pluripotent stem cells
granted -
US 8916184
Artificial tissue systems and uses thereof
granted -
US 8877204
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
granted -
US 8853205
Heteropyrrole analogs acting on cannabinoid receptors
granted -
US 8853228
Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
granted -
US 8785191
Concentration of stem cells obtained during orthopaedic surgeries
granted -
US 8765665
Albumin-free factor VIII formulations
granted -
US 8637506
Compositions and methods for bone formation and remodeling
granted -
US 8614189
Carbon nanotube composite scaffolds for bone tissue engineering
granted -
US 8591890
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
granted -
US 8563026
Protein-based artificial retinas
granted -
US 8545927
Lactoferrin-based biomaterials for tissue regeneration and drug delivery
granted -
US 8461155
Sclerostin and the inhibition of WNT signaling and bone formation
granted -
US 8426432
Inhibitors of dihydrofolate reductase with antibacterial antiprotozoal, antifungal and anticancer properties
granted -
US 8410097
Heteropyrrole analogs acting on cannabinoid receptors
granted -
US 8410078
Composition and methods to treat cardiac diseases
granted -
US 8372800
Albumin-free factor VIII formulations
granted